Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF – Get Free Report)’s share price fell 7.9% on Thursday . The company traded as low as $22.33 and last traded at $22.33. 204 shares were traded during mid-day trading, an increase of 10% from the average session volume of 186 shares. The stock had previously closed at $24.25.
Hikma Pharmaceuticals Stock Performance
The company has a quick ratio of 0.90, a current ratio of 1.57 and a debt-to-equity ratio of 0.47. The stock’s 50 day simple moving average is $24.18 and its two-hundred day simple moving average is $23.67.
Hikma Pharmaceuticals Increases Dividend
The firm also recently announced a dividend, which will be paid on Friday, May 3rd. Shareholders of record on Friday, March 22nd will be paid a $0.47 dividend. This is a positive change from Hikma Pharmaceuticals’s previous dividend of $0.25. The ex-dividend date of this dividend is Wednesday, March 20th.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- What is a Secondary Public Offering? What Investors Need to Know
- MarketBeat Week in Review – 4/15 – 4/19
- Stock Market Sectors: What Are They and How Many Are There?
- Comprehensive Analysis of PayPal Stock
- Energy and Oil Stocks Explained
- Intuitive Surgical Stock Can Trend Much Higher This Year
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
